{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:54:33Z","timestamp":1778547273047,"version":"3.51.4"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Highly malignant, RMS frequently fails to respond to conventional aggressive multimodal radiation, surgery, and chemotherapy treatment protocols that also cause significant sequelae in the growing child. Other tumors of mesenchymal origin, such as locally aggressive fibromatoses and desmoid tumors, have been successfully treated with a selective estrogen receptor (ER) modulator, tamoxifen. In an effort to identify new targets for RMS therapy, our group investigated the previously uncharacterized ER pathway in RMS cell culture and primary tumors. We detected ER isoform \u03b2 (ER\u03b2), but not isoform \u03b1, RNA, and protein in five RMS cell lines. Immunohistochemical staining of primary RMS tumor sections confirmed high levels of ER\u03b2 but not ER\u03b1 protein. RMS cell growth was dramatically inhibited in steroid-free conditions, and this growth inhibition was rescued with 17-\u03b2-estradiol (E2) supplementation. Exposure of RMS cells to 4\u2032OH-tamoxifen (4OHT) decreased cell viability and inhibited colony formation as detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and colony-forming assays. 4OHT also induced apoptotic signaling in RMS cells as detected by cleavage of caspase-3 and poly(ADP)ribose polymerase. This effect increased 3- to 8-fold in steroid-deprived conditions but was rescued by supplementation with E2. Immunofluorescence studies detected a change in the subcellular localization of ER\u03b2 in response to 4OHT. Together, these data suggest an active ER\u03b2-mediated signal transduction pathway in RMS. The ability of 4OHT to induce apoptotic signaling and disrupt estradiol-mediated proliferation provides a rationale to explore a role for selective ER modulators in the treatment of RMS. [Cancer Res 2008;68(9):3476\u201385]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-3046","type":"journal-article","created":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T21:11:48Z","timestamp":1209676308000},"page":"3476-3485","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Estrogen Receptor Pathway in Rhabdomyosarcoma: A Role for Estrogen Receptor-\u03b2 in Proliferation and Response to the Antiestrogen 4\u2032OH-Tamoxifen"],"prefix":"10.1158","volume":"68","author":[{"given":"Joshua A.","family":"Greenberg","sequence":"first","affiliation":[{"name":"1Division of Hematology\/Oncology and"},{"name":"3The Institute of Medical Science and Departments of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig","family":"Somme","sequence":"additional","affiliation":[{"name":"2General Surgery, The Hospital for Sick Children; and"},{"name":"6Surgery, University of Toronto, Toronto, Ontario, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hege E.","family":"Russnes","sequence":"additional","affiliation":[{"name":"7The Department of Pathology, The Norwegian Radiumhospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"Durbin","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology and"},{"name":"5Medical Biophysics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Malkin","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology and"},{"name":"3The Institute of Medical Science and Departments of"},{"name":"4Pediatrics,"},{"name":"5Medical Biophysics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2008,5,1]]},"reference":[{"key":"2022061700423741300_B1","doi-asserted-by":"crossref","unstructured":"Pappo AS. Rhabdomyosarcoma and other soft tissue sarcomas in children. Curr Opin Oncol\u20081996; 8: 311\u20136.","DOI":"10.1097\/00001622-199607000-00008"},{"key":"2022061700423741300_B2","unstructured":"Pizzo PA, Poplack DG. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2006; p. xiv, 1780."},{"key":"2022061700423741300_B3","unstructured":"Voute PA, Barrett A, Stevens CG, Caron HN. Cancer in Children: Clinical Management. 5th ed. Oxford University Press; 2005. p. 448."},{"key":"2022061700423741300_B4","doi-asserted-by":"crossref","unstructured":"Anderson J, Gordon A, McManus A, Shipley J, Pritchard-Jones K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia\u20081999; 1: 340\u20138.","DOI":"10.1038\/sj.neo.7900052"},{"key":"2022061700423741300_B5","doi-asserted-by":"crossref","unstructured":"Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer\u20082003; 107: 873\u20137.","DOI":"10.1002\/ijc.11487"},{"key":"2022061700423741300_B6","doi-asserted-by":"crossref","unstructured":"De Giovanni C, Melani C, Nanni P, et al. Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin. Br J Cancer\u20081995; 72: 1224\u20139.","DOI":"10.1038\/bjc.1995.490"},{"key":"2022061700423741300_B7","doi-asserted-by":"crossref","unstructured":"Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Oncogene\u20082005; 24: 8025\u201337.","DOI":"10.1038\/sj.onc.1208939"},{"key":"2022061700423741300_B8","unstructured":"Maloney EK, McLaughlin JL, Dagdigian NE, et al. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res\u20082003; 63: 5073\u201383."},{"key":"2022061700423741300_B9","doi-asserted-by":"crossref","unstructured":"Schweigerer L, Neufeld G, Mergia A, Abraham JA, Fiddes JC, Gospodarowicz D. Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci U S A\u20081987; 84: 842\u20136.","DOI":"10.1073\/pnas.84.3.842"},{"key":"2022061700423741300_B10","doi-asserted-by":"crossref","unstructured":"Xia SJ, Pressey JG, Barr FG. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther\u20082002; 1: 97\u2013104.","DOI":"10.4161\/cbt.51"},{"key":"2022061700423741300_B11","doi-asserted-by":"crossref","unstructured":"Zhan S, Shapiro DN, Helman LJ. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest\u20081994; 94: 445\u20138.","DOI":"10.1172\/JCI117344"},{"key":"2022061700423741300_B12","doi-asserted-by":"crossref","unstructured":"Kinzbrunner B, Ritter S, Domingo J, Rosenthal CJ. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer\u20081983; 52: 2201\u20134.","DOI":"10.1002\/1097-0142(19831215)52:12<2201::AID-CNCR2820521204>3.0.CO;2-#"},{"key":"2022061700423741300_B13","doi-asserted-by":"crossref","unstructured":"McAdam WA, Goligher JC. The occurrence of desmoids in patients with familial polyposis coli. Br J Surg\u20081970; 57: 618\u201331.","DOI":"10.1002\/bjs.1800570816"},{"key":"2022061700423741300_B14","doi-asserted-by":"crossref","unstructured":"Ohashi T, Shigematsu N, Kameyama K, Kubo A. Tamoxifen for recurrent desmoid tumor of the chest wall. Int J Clin Oncol\u20082006; 11: 150\u20132.","DOI":"10.1007\/s10147-005-0543-4"},{"key":"2022061700423741300_B15","doi-asserted-by":"crossref","unstructured":"Sportiello DJ, Hoogerland DL. A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer\u20081991; 67: 1443\u20136.","DOI":"10.1002\/1097-0142(19910301)67:5<1443::AID-CNCR2820670530>3.0.CO;2-X"},{"key":"2022061700423741300_B16","doi-asserted-by":"crossref","unstructured":"Ishizuka M, Hatori M, Dohi O, et al. Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med\u20082006; 210: 189\u201398.","DOI":"10.1620\/tjem.210.189"},{"key":"2022061700423741300_B17","doi-asserted-by":"crossref","unstructured":"Deyrup AT, Tretiakova M, Montag AG. Estrogen receptor-\u03b2 expression in extraabdominal fibromatoses: an analysis of 40 cases. Cancer\u20082006; 106: 208\u201313.","DOI":"10.1002\/cncr.21553"},{"key":"2022061700423741300_B18","doi-asserted-by":"crossref","unstructured":"Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev\u20082001; 81: 1535\u201365.","DOI":"10.1152\/physrev.2001.81.4.1535"},{"key":"2022061700423741300_B19","doi-asserted-by":"crossref","unstructured":"Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid\/thyroid receptor superfamily members. Annu Rev Biochem\u20081994; 63: 451\u201386.","DOI":"10.1146\/annurev.bi.63.070194.002315"},{"key":"2022061700423741300_B20","doi-asserted-by":"crossref","unstructured":"Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor \u03b2-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab\u20081997; 82: 4258\u201365.","DOI":"10.1210\/jc.82.12.4258"},{"key":"2022061700423741300_B21","doi-asserted-by":"crossref","unstructured":"Gosden JR, Middleton PG, Rout D. Localization of the human oestrogen receptor gene to chromosome 6q24\u2013q27 by in situ hybridization. Cytogenet Cell Genet\u20081986; 43: 218\u201320.","DOI":"10.1159\/000132325"},{"key":"2022061700423741300_B22","doi-asserted-by":"crossref","unstructured":"Dougherty SM, Mazhawidza W, Bohn AR, et al. Gender difference in the activity but not expression of estrogen receptors \u03b1 and \u03b2 in human lung adenocarcinoma cells. Endocr Relat Cancer\u20082006; 13: 113\u201334.","DOI":"10.1677\/erc.1.01118"},{"key":"2022061700423741300_B23","doi-asserted-by":"crossref","unstructured":"Martin LA, Pancholi S, Chan CM, et al. The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling. Endocr Relat Cancer\u20082005; 12: 1017\u201336.","DOI":"10.1677\/erc.1.00905"},{"key":"2022061700423741300_B24","doi-asserted-by":"crossref","unstructured":"Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor \u03b2 inhibits 17\u03b2-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A\u20082004; 101: 1566\u201371.","DOI":"10.1073\/pnas.0308319100"},{"key":"2022061700423741300_B25","unstructured":"Wakeling AE. Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res\u20081991; 51: 3867\u201373."},{"key":"2022061700423741300_B26","doi-asserted-by":"crossref","unstructured":"Shen SS, Smith CL, Hsieh JT, et al. Expression of estrogen receptors-\u03b1 and -\u03b2 in bladder cancer cell lines and human bladder tumor tissue. Cancer\u20082006; 106: 2610\u20136.","DOI":"10.1002\/cncr.21945"},{"key":"2022061700423741300_B27","doi-asserted-by":"crossref","unstructured":"McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP. Essential role for estrogen receptor \u03b2 in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology\u20082007; 148: 566\u201374.","DOI":"10.1210\/en.2006-0906"},{"key":"2022061700423741300_B28","doi-asserted-by":"crossref","unstructured":"Takahashi Y, Perkins SN, Hursting SD, Wang TT. 17\u03b2-estradiol differentially regulates androgen-responsive genes through estrogen receptor-\u03b2-and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells. Mol Carcinog\u20082007; 46: 117\u201329.","DOI":"10.1002\/mc.20254"},{"key":"2022061700423741300_B29","doi-asserted-by":"crossref","unstructured":"Ohshiro K, Rayala SK, Williams MD, Kumar R, El-Naggar AK. Biological role of estrogen receptor \u03b2 in salivary gland adenocarcinoma cells. Clin Cancer Res\u20082006; 12: 5994\u20139.","DOI":"10.1158\/1078-0432.CCR-06-1251"},{"key":"2022061700423741300_B30","doi-asserted-by":"crossref","unstructured":"Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou AG, Agnantis NJ. Estrogen receptor \u03b2 (ER\u03b2) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol\u20082004; 130: 405\u201310.","DOI":"10.1007\/s00432-004-0548-9"},{"key":"2022061700423741300_B31","unstructured":"Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ER\u03b2 isoforms in colon cancer. Cancer Res\u20082001; 61: 632\u201340."},{"key":"2022061700423741300_B32","doi-asserted-by":"crossref","unstructured":"Gruvberger-Saal SK, Bendahl PO, Saal LH, et al. Estrogen receptor {\u03b2} expression is associated with tamoxifen response in ER{\u03b1}-negative breast carcinoma. Clin Cancer Res\u20082007; 13: 1987\u201394.","DOI":"10.1158\/1078-0432.CCR-06-1823"},{"key":"2022061700423741300_B33","doi-asserted-by":"crossref","unstructured":"Zacharin M, Waters K, Chow CW, Crock P, McKelvie P. Recurrent rhabdomyosarcoma after 25 years: a possible association with estrogen and progestogen therapy. J Pediatr Hematol Oncol\u20081997; 19: 477\u201381.","DOI":"10.1097\/00043426-199709000-00015"},{"key":"2022061700423741300_B34","doi-asserted-by":"crossref","unstructured":"Gottardis MM, Robinson SP, Jordan VC. Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen. J Steroid Biochem\u20081998; 30: 311\u20134.","DOI":"10.1016\/0022-4731(88)90113-6"},{"key":"2022061700423741300_B35","doi-asserted-by":"crossref","unstructured":"Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L, Jr. A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Update\u20082000; 6: 212\u201324.","DOI":"10.1093\/humupd\/6.3.212"},{"key":"2022061700423741300_B36","doi-asserted-by":"crossref","unstructured":"Chagin AS, Karimian E, Zaman F, Takigawa M, Chrysis D, Savendahl L. Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones. Bone\u20082007; 40: 1415\u201324.","DOI":"10.1016\/j.bone.2006.12.066"},{"key":"2022061700423741300_B37","doi-asserted-by":"crossref","unstructured":"Wu X, Ahn EY, McKenna MA, Yeo H, McDonald JM. Fas binding to calmodulin regulates apoptosis in osteoclasts. J Biol Chem\u20082005; 280: 29964\u201370.","DOI":"10.1074\/jbc.M500710200"},{"key":"2022061700423741300_B38","doi-asserted-by":"crossref","unstructured":"Wilcken N, Tattersall MH. Endocrine therapy for desmoid tumors. Cancer\u20081991; 68: 1384\u20138.","DOI":"10.1002\/1097-0142(19910915)68:6<1384::AID-CNCR2820680634>3.0.CO;2-F"},{"key":"2022061700423741300_B39","doi-asserted-by":"crossref","unstructured":"Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S. Differential response of estrogen receptor \u03b1 and estrogen receptor \u03b2 to partial estrogen agonists\/antagonists. Mol Pharmacol\u20081998; 54: 105\u201312.","DOI":"10.1124\/mol.54.1.105"},{"key":"2022061700423741300_B40","doi-asserted-by":"crossref","unstructured":"Dauvois S, White R, Parker MG. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci\u20081993; 106: 1377\u201388.","DOI":"10.1242\/jcs.106.4.1377"},{"key":"2022061700423741300_B41","doi-asserted-by":"crossref","unstructured":"Lee H, Bai W. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol Cell Biol\u20082002; 22: 5835\u201345.","DOI":"10.1128\/MCB.22.16.5835-5845.2002"},{"key":"2022061700423741300_B42","doi-asserted-by":"crossref","unstructured":"Metzger D, Ali S, Bornert JM, Chambon P. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem\u20081995; 270: 9535\u201342.","DOI":"10.1074\/jbc.270.16.9535"},{"key":"2022061700423741300_B43","doi-asserted-by":"crossref","unstructured":"Zheng A, Kallio A, Harkonen P. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via ERK signaling and can be abrogated by estrogen. Endocrinology\u20082007; 148: 2764\u201377.","DOI":"10.1210\/en.2006-1269"},{"key":"2022061700423741300_B44","doi-asserted-by":"crossref","unstructured":"Rodriguez-Galindo C, Hill DA, Onyekwere O, et al. Neonatal alveolar rhabdomyosarcoma with skin and brain metastases. Cancer\u20082001; 92: 1613\u201320.","DOI":"10.1002\/1097-0142(20010915)92:6<1613::AID-CNCR1487>3.0.CO;2-N"},{"key":"2022061700423741300_B45","doi-asserted-by":"crossref","unstructured":"Parham DM. Appearances may be deceiving: does aggressive histology correlate with behavior of infantile sarcomas? Pediatr Dev Pathol\u20082002; 5: 513\u20134.","DOI":"10.1007\/s10024-002-0084-z"},{"key":"2022061700423741300_B46","doi-asserted-by":"crossref","unstructured":"Arts J, Kuiper GG, Janssen JM, et al. Differential expression of estrogen receptors \u03b1 and \u03b2 mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology\u20081997; 138: 5067\u201370.","DOI":"10.1210\/endo.138.11.5652"},{"key":"2022061700423741300_B47","doi-asserted-by":"crossref","unstructured":"Sorensen MG, Henriksen K, Dziegiel MH, Tanko LB, Karsdal MA. Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts. DNA Cell Biol\u20082006; 25: 475\u201383.","DOI":"10.1089\/dna.2006.25.475"},{"key":"2022061700423741300_B48","doi-asserted-by":"crossref","unstructured":"Andersen J, Orntoft T, Skorvgaard Poulsen H. Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies. Br J Cancer\u20081986; 53: 691\u20134.","DOI":"10.1038\/bjc.1986.114"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/9\/3476\/2602791\/3476.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/9\/3476\/2602791\/3476.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:41:26Z","timestamp":1655433686000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/9\/3476\/543323\/The-Estrogen-Receptor-Pathway-in-Rhabdomyosarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2008,5,1]]},"published-print":{"date-parts":[[2008,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-3046","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1115151.571140","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}